Pharma Globenewswire - Page 452 of 489 - Press Release And News Distribution

Suggestions

Press Release And News Distribution

News
Drug Launches & Approvals
Clinical Trials
Market Insights
Artificial Intelligence
Commercial
More

Latest

Search

Recent Posts

Acute Kidney Injury Market and Pipeline Appear Robust With Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight
ARO-C3 Market Forecast Highlights Emerging Opportunities in Complement-Mediated Kidney Diseases
Familial Adenomatous Polyposis Market and Pipeline Appear Robust With Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight
ARO-AAT Market Forecast Highlights Emerging Opportunities in Alpha-1 Antitrypsin Deficiency Liver Disease Treatment
ENTYVIO (Vedolizumab) Market Forecast Highlights Growing Competition in Crohn’s Disease Treatment

Banner

Newsletter

Authors

pharmaglobenews

Acute Kidney Injury Market and Pipeline Appear Robust With Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight
Michael Ashford

Motor Neuron Disease Pipeline Insight 2026: Driving Hope Through Next-Generation Therapies

© 2026 - ALL RIGHTS RESERVED.
Pharma GlobeNewswire is a specialized press release distribution platform focused on the pharmaceutical, biotechnology, and healthcare sectors. It enables companies to share news related to drug development, clinical trials, regulatory updates, market insights, and corporate announcements with a global audience. By leveraging targeted distribution channels, Pharma GlobeNewswire helps organizations enhance visibility, reach industry stakeholders, and amplify their brand presence within the life sciences ecosystem.

About
Privacy
Help
Terms
Contact

Popular

NCFB Market on the Brink of Change as First DPP1 Inhibitor Marks Approval | DelveInsight

The NCFB market is entering a new phase as Insmed’s

News
Drug Launches & Approvals
Clinical Trials
Market Insights
Artificial Intelligence
Commercial
More